sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Angiotensin Converting Enzyme Ace Inhibitors Market Scope And Analysis

  • Report Code : TIPRE00020853
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Analisi del mercato degli inibitori dell'enzima di conversione dell'angiotensina (ACE) e dei concorrenti entro il 2025-2031

Buy Now

Angiotensin Converting Enzyme (ACE) Inhibitors Market Report Angiotensin Converting Enzyme (ACE) Inhibitors Market Size and Share Angiotensin Converting Enzyme (ACE) Inhibitors Market Scope and Analysis

Angiotensin Converting Enzyme (ACE) Inhibitors Market Report Scope

Report Attribute Details
Market size in 2023 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Prodotto
  • Benazepril
  • Captopril
  • Enalapril
  • Fosinopril
  • Lisinopril
  • Altri
By Indicazione
  • malattie cardiovascolari
  • ipertensione
  • malattie renali croniche
  • diabete
  • sclerodermia
  • emicrania
By Canale di distribuzione
  • farmacie online
  • farmacie al dettaglio e farmacie ospedaliere
By Geografia
  • America del Nord
  • Europa
  • Asia-Pacifico
  • America centrale e meridionale
Regions and Countries Covered Nord America
  • Stati Uniti
  • Canada
  • Messico
Europa
  • Regno Unito
  • Germania
  • Francia
  • Russia
  • Italia
  • Resto Europa
Asia-Pacifico
  • Cina
  • India
  • Giappone
  • Australia
  • resto delAsia-Pacifico
America centrale e meridionale
  • Brasile
  • Argentina
  • Resto delAmerica Centrale e Meridionale
Medio Oriente e Africa
  • Sudafrica
  • Arabia Saudita
  • Emirati Arabi Uniti
  • Resto del Medio Oriente e Africa
Market leaders and key company profiles
  • Novartis AG
  • Pfizer, Inc
  • Merck & Co., Inc.
  • Bristol Myers Squibb
  • Astra and Zeneca
  • UCB (Schwarz Pharma Inc.)
  • Solvay Pharmaceuticals B.V.
  • Abbott
  • Endo International (Par Pharmaceutical, Inc.)